Not applicableActive Not RecruitingNCT06315361What this trial is testingDIAbetes and NAFLDWho this might be right forNAFLDDiabetesNASH+3 more Fondazione Policlinico Universitario Agostino Gemelli IRCCS 600
Not applicableNot Yet RecruitingNCT07168551What this trial is testingIs There a Relationship Between Uric Acid Level and Liver Fibrosis in Obese PatientsWho this might be right forHyperuricemiaNAFLD (Nonalcoholic Fatty Liver Disease)Liver Fibrosis Assiut University 111
Not applicableLooking for participantsNCT05974904What this trial is testingAssociation of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional StudyWho this might be right forMetabolic Dysfunction-associated Fatty Liver DiseaseHepatic SteatosisLiver Fibrosis Chongqing Medical University 7,000
Testing effectiveness (Phase 2)Looking for participantsNCT05832229What this trial is testingLiver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United StatesWho this might be right forCirrhosisCirrhosis, LiverCirrhosis Early+5 more National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 256
Not applicableNot Yet RecruitingNCT06537466What this trial is testingKetogenic Diet in MASLD-related cACLDWho this might be right forSteatohepatitis, NonalcoholicSteatosis of LiverCirrhosis, Liver University of Palermo 50
Not applicableStudy completedNCT04435054What this trial is testingScreening for NAFLD-related Advanced Fibrosis in High Risk Population in Diabetology.Who this might be right forNon-Alcoholic Fatty Liver Disease Hospices Civils de Lyon 1,000
Large-scale testing (Phase 3)Looking for participantsNCT06461208What this trial is testingA PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With CirrhosisWho this might be right forLiver Cirrhosis King's College London 300
Not applicableStudy completedNCT03663062What this trial is testingObeSity Related Colorectal Adenoma RiskWho this might be right forColorectal AdenomaColorectal NeoplasmColorectal Cancer+4 more South Tyneside and Sunderland NHS Foundation Trust 1,430
Not applicableLooking for participantsNCT05699018What this trial is testingScreening in Primary Care of Advanced Liver Fibrosis in NAFLD And/or Alcoholic PatientsWho this might be right forNon-alcoholic Fatty Liver Disease (NAFLD)Alcoholic Liver Disease (ALD)Liver Fibrosis University Hospital, Angers 1,788
Testing effectiveness (Phase 2)Ended earlyNCT02193867What this trial is testingClinical Study In Infants With Rapidly Progressive Lysosomal Acid Lipase DeficiencyWho this might be right forLysosomal Acid Lipase Deficiency Alexion Pharmaceuticals, Inc. 10
Not applicableNot Yet RecruitingNCT06773221What this trial is testingThe Efficacy and Safety of Chiglitazar in Patients with MAFLD-related CirrhosisWho this might be right forMetabolic Dysfunction Associated Fatty Liver DiseaseCompensated Liver Cirrhosis Beijing Friendship Hospital 195
Not applicableUnknownNCT04493814What this trial is testingStudy Visceral Adipose Tissue and Liver Stifness in a Retrospective Cohort of Diabetes Mellitus PatientsWho this might be right forNAFLDType 2 Diabetes Central Hospital, Nancy, France 86
Not applicableNot Yet RecruitingNCT06364462What this trial is testingPrecise Evaluation Criteria for Histological Regression of NASH FibrosisWho this might be right forNASHLiver Fibrosis Beijing Friendship Hospital 220
Not applicableUnknownNCT02721264What this trial is testingFecal Microbiota Therapy Versus Standard Therapy in NASH Related Cirrhosis.Who this might be right forNon Alcoholic Steatohepatitis Institute of Liver and Biliary Sciences, India 112
Not applicableLooking for participantsNCT05385237What this trial is testingIdentification of Hepatic Fibrosis Using 4D-MRIWho this might be right forLiver Diseases University Hospital, Basel, Switzerland 200
Not applicableWithdrawnNCT02868164What this trial is testingFecal Microbiota Therapy Versus Standard Therapy in Decompensated NASH Related Cirrhosis: A Randomized Controlled Trial.Who this might be right forNASH Related Decompensated Cirrhosis Institute of Liver and Biliary Sciences, India
Large-scale testing (Phase 3)Study completedNCT01371825What this trial is testingSafety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Sebelipase Alfa in Children With Growth Failure Due to Lysosomal Acid Lipase DeficiencyWho this might be right forLysosomal Acid Lipase DeficiencyWolman Disease Alexion Pharmaceuticals, Inc. 9
Not applicableStudy completedNCT02234440What this trial is testingEffect of Metformin on Disease Progression in Patients With Cryptogenic Cirrhosis (NASH-related Cirrhosis) With Diabetes or Impaired Glucose Tolerance or Insulin ResistanceWho this might be right forNASH Related Cirrhosis Institute of Liver and Biliary Sciences, India 86
Large-scale testing (Phase 3)Active Not RecruitingNCT05500222What this trial is testingEvaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)Who this might be right forNASHCirrhosis, Liver Madrigal Pharmaceuticals, Inc. 700
Large-scale testing (Phase 3)Looking for participantsNCT06632457What this trial is testingLIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have CirrhosisWho this might be right forMetabolic Dysfunction Associated Steatohepatitis Boehringer Ingelheim 1,590